Long Versus Short Axis Approach for Ultrasound Guided Peripheral Intravenous Access
Launched by TEMPLE UNIVERSITY · Jan 16, 2020
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to find out which method works better for placing a peripheral intravenous (IV) line using ultrasound guidance: the long axis approach or the short axis approach. This trial is important because a good IV placement is essential for delivering medications and fluids to patients.
To participate in this trial, you need to be between the ages of 6 and 75 and should be stable in your health condition, meaning your vital signs are normal and you don’t have any major issues affecting your blood flow. Unfortunately, if you are not stable or cannot agree to participate (consent), you won't be eligible for this study. If you do join, the trial will compare the two methods to see which one is more effective for getting the IV in place. The trial is currently not recruiting participants, but it aims to help improve IV placement techniques in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hemodynamically stable patients requiring placement of an USGPIV.
- Exclusion Criteria:
- • Hemodynamically unstable
- • Unable to consent
About Temple University
Temple University is a leading academic institution located in Philadelphia, Pennsylvania, renowned for its commitment to research and innovation in the health sciences. As a clinical trial sponsor, Temple University leverages its extensive resources, including a diverse pool of participants and cutting-edge facilities, to advance medical knowledge and improve patient care. The university's clinical research initiatives are driven by a multidisciplinary team of experts dedicated to conducting high-quality studies that address critical health issues and contribute to the development of novel therapies. Through its partnerships with local and global organizations, Temple University aims to enhance the translation of research findings into practical applications that benefit communities and advance public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Ryan C Gibbons, MD
Principal Investigator
Temple University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials